Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eric T. Wong, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R03CA172923 (WONG, ERIC T) Apr 1, 2013 - Mar 31, 2015
    NIH/NCI
    The Role of Post Traumatic Stress and Substance P in Melanoma Brain Metastasis
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Timmons JJ, Zhang K, Fong J, Lok E, Swanson KD, Gautam S, Wong ET. Literature Review of Spinal Cord Glioblastoma. Am J Clin Oncol. 2018 Dec; 41(12):1281-1287. PMID: 29528867.
    View in: PubMed
  2. Timmons JJ, Preto J, Tuszynski JA, Wong ET. Tubulin's response to external electric fields by molecular dynamics simulations. PLoS One. 2018; 13(9):e0202141. PMID: 30231050.
    View in: PubMed
  3. Coulter ME, Dorobantu CM, Lodewijk GA, Delalande F, Cianferani S, Ganesh VS, Smith RS, Lim ET, Xu CS, Pang S, Wong ET, Lidov HGW, Calicchio ML, Yang E, Gonzalez DM, Schlaeger TM, Mochida GH, Hess H, Lee WA, Lehtinen MK, Kirchhausen T, Haussler D, Jacobs FMJ, Gaudin R, Walsh CA. The ESCRT-III Protein CHMP1A Mediates Secretion of Sonic Hedgehog on a Distinctive Subtype of Extracellular Vesicles. Cell Rep. 2018 Jul 24; 24(4):973-986.e8. PMID: 30044992.
    View in: PubMed
  4. Wong ET, Lok E, Swanson KD. Alternating Electric Fields Therapy for Malignant Gliomas: From Bench Observation to Clinical Reality. Prog Neurol Surg. 2018; 32:180-195. PMID: 29990984.
    View in: PubMed
  5. Wong ET, Swanson KD. Everolimus shortens survival of newly diagnosed glioblastoma patients. J Neurooncol. 2018 Oct; 140(1):179-180. PMID: 29956084.
    View in: PubMed
  6. Timmons JJ, Lok E, San P, Bui K, Wong ET. End-to-end workflow for finite element analysis of tumor treating fields in glioblastomas. Phys Med Biol. 2017 Oct 12; 62(21):8264-8282. PMID: 29023236.
    View in: PubMed
  7. Lok E, San P, Hua V, Phung M, Wong ET. Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma. Cancer Med. 2017 Jun; 6(6):1286-1300. PMID: 28544575.
    View in: PubMed
  8. Wong ET, Timmons J, Callahan A, O'Loughlin L, Giarusso B, Alsop DC. Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas. BMC Cancer. 2016 11 22; 16(1):914. PMID: 27876012.
    View in: PubMed
  9. Zhao L, Dai W, Soman S, Hackney DB, Wong ET, Robson PM, Alsop DC. Using Anatomic Magnetic Resonance Image Information to Enhance Visualization and Interpretation of Functional Images: A Comparison of Methods Applied to Clinical Arterial Spin Labeling Images. IEEE Trans Med Imaging. 2017 02; 36(2):487-496. PMID: 27723582.
    View in: PubMed
  10. Timmons JJ, Cohessy S, Wong ET. Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs. J Vis Exp. 2016 05 24; (111). PMID: 27285567.
    View in: PubMed
  11. Lee EQ, Muzikansky A, Drappatz J, Kesari S, Wong ET, Fadul CE, Reardon DA, Norden AD, Nayak L, Rinne ML, Alexander BM, Arvold ND, Doherty L, Stefanik J, LaFrankie D, Ruland SF, Pulverenti J, Smith KH, Gaffey SC, Hammond S, Wen PY. A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy. Neuro Oncol. 2016 06; 18(6):849-54. PMID: 26902850; PMCID: PMC4864265 [Available on 06/01/17].
  12. Fonkem E, Dayawansa S, Stroberg E, Lok E, Bricker PC, Kirmani B, Wong ET, Huang JH. Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. BMC Neurol. 2016 Jan 16; 16:9. PMID: 26849888; PMCID: PMC4744383.
  13. Swanson KD, Lok E, Wong ET. An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma. Curr Neurol Neurosci Rep. 2016 Jan; 16(1):8. PMID: 26739692; PMCID: PMC4703612.
  14. Mahadevan A, Sampson C, LaRosa S, Floyd SR, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM. Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy. Radiat Oncol. 2015 Nov 26; 10:245. PMID: 26611656; PMCID: PMC4662000.
  15. Ippen FM, Mahadevan A, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM. Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection. J Oncol. 2015; 2015:636918. PMID: 26681942; PMCID: PMC4668321.
  16. Wong ET, Toms SA, Ahluwalia MS. Clinical Use of Tumor Treating Fields: Discussion. Clin Adv Hematol Oncol. 2015 Nov; 13(11 Suppl 11):16-7. PMID: 26862773.
    View in: PubMed
  17. Wong ET. Clinical Use of Tumor Treating Fields and Other New Technologies in Cancer. Clin Adv Hematol Oncol. 2015 Nov; 13(11 Suppl 11):8-12. PMID: 26862771.
    View in: PubMed
  18. Lok E, Swanson KD, Wong ET. Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations. Expert Rev Med Devices. 2015; 12(6):717-26. PMID: 26513694.
    View in: PubMed
  19. Wong ET, Swanson KD. Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'. Br J Cancer. 2015 Dec 01; 113(11):1633-4. PMID: 26348442; PMCID: PMC4705876.
  20. Lok E, Hua V, Wong ET. Computed modeling of alternating electric fields therapy for recurrent glioblastoma. Cancer Med. 2015 Nov; 4(11):1697-9. PMID: 26311253.
    View in: PubMed
  21. Christ SM, Mahadevan A, Floyd SR, Lam FC, Chen CC, Wong ET, Kasper EM. Stereotactic radiosurgery for brain metastases from malignant melanoma. Surg Neurol Int. 2015; 6(Suppl 12):S355-65. PMID: 26392919; PMCID: PMC4553636.
  22. Wong ET, Lok E, Swanson KD. An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas. Curr Treat Options Oncol. 2015 Aug; 16(8):40. PMID: 26143265; PMCID: PMC4491358.
  23. Gera N, Yang A, Holtzman TS, Lee SX, Wong ET, Swanson KD. Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS One. 2015; 10(5):e0125269. PMID: 26010837; PMCID: PMC4444126.
  24. Lee EQ, Kaley TJ, Duda DG, Schiff D, Lassman AB, Wong ET, Mikkelsen T, Purow BW, Muzikansky A, Ancukiewicz M, Huse JT, Ramkissoon S, Drappatz J, Norden AD, Beroukhim R, Weiss SE, Alexander BM, McCluskey CS, Gerard M, Smith KH, Jain RK, Batchelor TT, Ligon KL, Wen PY. A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients. Clin Cancer Res. 2015 Aug 15; 21(16):3610-8. PMID: 25910950; PMCID: PMC4790106.
  25. Rangachari D, Yamaguchi N, VanderLaan PA, Folch E, Mahadevan A, Floyd SR, Uhlmann EJ, Wong ET, Dahlberg SE, Huberman MS, Costa DB. Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers. Lung Cancer. 2015 Apr; 88(1):108-11. PMID: 25682925.
    View in: PubMed
  26. Wong ET, Lok E, Swanson KD. Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation. Cancer Med. 2015 Mar; 4(3):383-91. PMID: 25620708; PMCID: PMC4380964.
  27. Norden AD, Ligon KL, Hammond SN, Muzikansky A, Reardon DA, Kaley TJ, Batchelor TT, Plotkin SR, Raizer JJ, Wong ET, Drappatz J, Lesser GJ, Haidar S, Beroukhim R, Lee EQ, Doherty L, Lafrankie D, Gaffey SC, Gerard M, Smith KH, McCluskey C, Phuphanich S, Wen PY. Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma. Neurology. 2015 Jan 20; 84(3):280-6. PMID: 25527270; PMCID: PMC4335993.
  28. Vymazal J, Wong ET. Response patterns of recurrent glioblastomas treated with tumor-treating fields. Semin Oncol. 2014 Oct; 41 Suppl 6:S14-24. PMID: 25213870.
    View in: PubMed
  29. Kanner AA, Wong ET, Villano JL, Ram Z. Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapy. Semin Oncol. 2014 Oct; 41 Suppl 6:S25-34. PMID: 25213871.
    View in: PubMed
  30. Fonkem E, Lok E, Robison D, Gautam S, Wong ET. The natural history of intravascular lymphomatosis. Cancer Med. 2014 Aug; 3(4):1010-24. PMID: 24931821; PMCID: PMC4303169.
  31. Scheidegger R, Wong ET, Alsop DC. Contributors to contrast between glioma and brain tissue in chemical exchange saturation transfer sensitive imaging at 3 Tesla. Neuroimage. 2014 Oct 01; 99:256-68. PMID: 24857712; PMCID: PMC4386907.
  32. Elzinga G, Wong ET. Resolution of cystic enhancement to add-on tumor treating electric fields for recurrent glioblastoma after incomplete response to bevacizumab. Case Rep Neurol. 2014 Jan; 6(1):109-15. PMID: 24847254; PMCID: PMC4025148.
  33. Lok E, Chung AS, Swanson KD, Wong ET. Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid. Melanoma Res. 2014 Apr; 24(2):120-30. PMID: 24463459; PMCID: PMC3943890.
  34. Lacouture ME, Davis ME, Elzinga G, Butowski N, Tran D, Villano JL, DiMeglio L, Davies AM, Wong ET. Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma. Semin Oncol. 2014 Jun; 41 Suppl 4:S1-14. PMID: 24794308.
    View in: PubMed
  35. Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL. Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma. Cancer Med. 2014 Jun; 3(3):592-602. PMID: 24574359; PMCID: PMC4101750.
  36. Butowski N, Wong ET, Mehta MP, Wilson LK. A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields. Semin Oncol. 2013 Dec; 40(6):S2-4. PMID: 24331200.
    View in: PubMed
  37. Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA, Loguidice L, Soto H, Garrett M, Zhu LD, Sivaraman S, Chen C, Wong ET, Carter BS, Hochberg FH, Breakefield XO, Skog J. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Mol Ther Nucleic Acids. 2013 Jul 23; 2:e109. PMID: 23881452; PMCID: PMC3732870.
  38. Zhu JJ, Wong ET. Personalized medicine for glioblastoma: current challenges and future opportunities. Curr Mol Med. 2013 Mar; 13(3):358-67. PMID: 23331008.
    View in: PubMed
  39. Recht L, Mechtler LL, Wong ET, O'Connor PC, Rodda BE. Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy. J Clin Oncol. 2013 Mar 20; 31(9):1182-7. PMID: 23382470.
    View in: PubMed
  40. Drappatz J, Brenner A, Wong ET, Eichler A, Schiff D, Groves MD, Mikkelsen T, Rosenfeld S, Sarantopoulos J, Meyers CA, Fielding RM, Elian K, Wang X, Lawrence B, Shing M, Kelsey S, Castaigne JP, Wen PY. Phase I study of GRN1005 in recurrent malignant glioma. Clin Cancer Res. 2013 Mar 15; 19(6):1567-76. PMID: 23349317.
    View in: PubMed
  41. Lu R, Wu C, Guo L, Liu Y, Mo W, Wang H, Ding J, Wong ET, Yu M. The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo. BMC Cancer. 2012 Dec 19; 12:607. PMID: 23253190; PMCID: PMC3575301.
  42. Floyd SR, Kasper EM, Uhlmann EJ, Fonkem E, Wong ET, Mahadevan A. Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial. Front Oncol. 2012; 2:122. PMID: 23087896; PMCID: PMC3472503.
  43. Fonkem E, Uhlmann EJ, Floyd SR, Mahadevan A, Kasper E, Eton O, Wong ET. Melanoma brain metastasis: overview of current management and emerging targeted therapies. Expert Rev Neurother. 2012 Oct; 12(10):1207-15. PMID: 23082737.
    View in: PubMed
  44. Yu A, Teich DL, Moonis G, Wong ET. Superior semicircular canal dehiscence in East Asian women with osteoporosis. BMC Ear Nose Throat Disord. 2012 Jul 25; 12:8. PMID: 22831544; PMCID: PMC3503862.
  45. Fonkem E, Wong ET. NovoTTF-100A: a new treatment modality for recurrent glioblastoma. Expert Rev Neurother. 2012 Aug; 12(8):895-9. PMID: 22708931.
    View in: PubMed
  46. Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012 Sep; 48(14):2192-202. PMID: 22608262.
    View in: PubMed
  47. Locasale JW, Melman T, Song S, Yang X, Swanson KD, Cantley LC, Wong ET, Asara JM. Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. Mol Cell Proteomics. 2012 Jun; 11(6):M111.014688. PMID: 22240505; PMCID: PMC3433896.
  48. Gutin PH, Wong ET. Noninvasive application of alternating electric fields in glioblastoma: a fourth cancer treatment modality. Am Soc Clin Oncol Educ Book. 2012; 126-31. PMID: 24451721.
    View in: PubMed
  49. Fonkem E, Lun M, Wong ET. Rare phenomenon of extracranial metastasis of glioblastoma. J Clin Oncol. 2011 Dec 01; 29(34):4594-5. PMID: 22042941.
    View in: PubMed
  50. Wang CC, Floyd SR, Chang CH, Warnke PC, Chio CC, Kasper EM, Mahadevan A, Wong ET, Chen CC. Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. J Neurooncol. 2012 Feb; 106(3):601-10. PMID: 21879395.
    View in: PubMed
  51. Lun M, Lok E, Gautam S, Wu E, Wong ET. The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol. 2011 Nov; 105(2):261-73. PMID: 21512826.
    View in: PubMed
  52. Wong ET, Gautam S, Malchow C, Lun M, Pan E, Brem S. Bevacizumab for recurrent glioblastoma multiforme: a meta-analysis. J Natl Compr Canc Netw. 2011 Apr; 9(4):403-7. PMID: 21464145.
    View in: PubMed
  53. Lehtinen MK, Zappaterra MW, Chen X, Yang YJ, Hill AD, Lun M, Maynard T, Gonzalez D, Kim S, Ye P, D'Ercole AJ, Wong ET, LaMantia AS, Walsh CA. The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. Neuron. 2011 Mar 10; 69(5):893-905. PMID: 21382550; PMCID: PMC3085909.
  54. Jia Y, Kraus JA, Reddy H, Groff M, Wong ET. Polyradiculopathies from schwannomatosis. Open Neuroimag J. 2011; 5:9-13. PMID: 21643503.
    View in: PubMed
  55. Sengupta S, Pedersen NP, Davis JE, Rojas R, Reddy H, Kasper E, Greenstein P, Wong ET. Illusion of stroke: intravascular lymphomatosis. Rev Neurol Dis. 2011; 8(3-4):e107-13. PMID: 22249564.
    View in: PubMed
  56. Wong ET, Brem S. Taming glioblastoma by targeting angiogenesis: 3 years later. J Clin Oncol. 2011 Jan 10; 29(2):124-6. PMID: 21135277.
    View in: PubMed
  57. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010 Apr 10; 28(11):1963-72. PMID: 20231676.
    View in: PubMed
  58. Drappatz J, Norden AD, Wong ET, Doherty LM, Lafrankie DC, Ciampa A, Kesari S, Sceppa C, Gerard M, Phan P, Schiff D, Batchelor TT, Ligon KL, Young G, Muzikansky A, Weiss SE, Wen PY. Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):85-90. PMID: 20137866.
    View in: PubMed
  59. Wong ET, Barron L, Bloom J, Hackney D, Alsop D. Phase I study of metronomic temozolomide and arterial spin labeling perfusion measurements for recurrent glioblastoma multiforme. Neuro-Oncology. 2009.
  60. Swanson K, Lok E, Song S, Dessain J, Wong ET. Cerebrospinal fluid (CSF) biomarkers for breast cancer (BC) brain metastases. Annals of Neurology. 2009.
  61. Wong ET, Barron L, Bloom J, Hackney D, Alsop D. Arterial spin labeling (ASL) perfusion imaging for anti-angiogenic drug treatment of malignant gliomas. Sixth Annual World Congress for Brain Mapping and Image Guided Therapy. 2009; OP2.02.
  62. Park S, Zhao D, Hatanpaa KJ, Mickey BE, Saha D, Boothman DA, Story MD, Wong ET, Burma S, Georgescu MM, Rangnekar VM, Chauncey SS, Habib AA. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Cancer Res. 2009 May 15; 69(10):4107-11. PMID: 19435890; PMCID: PMC2683913.
  63. Swanson K, Lok E, Song S, Dessain J, Wong ET. Cerebrospinal fluid (CSF) biomarkers for breast cancer (BC) brain metastases. The Sixth Annual Symposium of the Dana –Farber/Harvard Cancer Center Program in Breast Cancer. 2009.
  64. Brem S, Wong ET. Angiogenesis and brain tumors: Molecular targets and molecular scalpels. Youman's Textbook of Neurosurgery. 2009; in press.
  65. Drappatz J, Norden AD, Wong ET, Doherty LM, LaFrankie DC, Ciampa A, Kesari S, Sceppa C, Gerard M, Phan P, Schiff D, Batchelor TT, Lassman A, Ligon KL, Young G, Muzikansky A, Weiss S, Wen PY. Phase I study of vandetanib with radiation therapy and temozolomide for newly-diagnosed glioblastoma. International Journal of Radiation Oncology Biology Physics. 2009; in press.
  66. Castaigne JP, Mikkelsen T, Schiff D, Wen P, Rosenfeld S, Groves M, Wong ET, Elian KM, Neale A, Lawrence B, Drappatz J. ANG1005 (Angiopep-2/paclitaxel conjugate) as a promising new drug therapy for patients with malignant glioma. Proceedings of the 100th Annual Meeting of the American Association for Cancer Research. 2009; Abstract 3781.
  67. Mechtler L, Wong ET, Hormigo A, Pannullo S, Hines V, Milsted R, O’Connor PC, Ryan RP, Recht L. A long-term open-label extension study examining the steroid-sparing effects of corticorelin acetate in patients with cerebral tumors. Proceed ASCO. 2009; 27:106s.
  68. Recht L, Mechtler L, Phuphanich S, Hormigo A, Hines V, Milstead R, O’Connor PC, Ryan RP, Wong ET. A placebo-controlled study investigating the dexamethasone sparing effects of corticorelin acetate in patients with cerebral tumors and peritumoral edema. Proceed ASCO. 2009; 27:106s.
  69. Drappatz J, Norden A, Wong ET, Doherty L, LaFrankie D, Lassman AB, Gerard M, Phan P, Schiff D, Wen PY. Phase I study of vandtanib with radiation therapy and temozolomide for newly-diagnosed glioblastoma. Proceed ASCO. 2009; 27:94s.
  70. Wong ET, Huberman M, Lu XQ, Mahadevan A. Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol. 2008 Dec 01; 26(34):5649-50. PMID: 18981459.
    View in: PubMed
  71. Drappatz J, Wong ET, Schiff D, Kesari S, Batchelor TT, Doherty L, Lafrankie DC, Ramakrishna N, Weiss S, Smith ST, Ciampa A, Zimmerman J, Ostrowsky L, David K, Norden A, Barron L, Sceppa C, Black PM, Wen PY. A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):222-7. PMID: 18513880.
    View in: PubMed
  72. Wong ET, Brem S. Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities. J Natl Compr Canc Netw. 2008 May; 6(5):515-22. PMID: 18492463.
    View in: PubMed
  73. Lu XQ, Shanmugham LN, Mahadevan A, Nedea E, Stevenson MA, Kaplan I, Wong ET, La Rosa S, Wang F, Berman SM. Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):281-9. PMID: 18406892.
    View in: PubMed
  74. Chowdhary S, Wong ET. Bevacizumab combined with irinotecan for recurrent glioblastoma multiforme--improvement over available therapy? Nat Clin Pract Neurol. 2008 May; 4(5):242-3. PMID: 18212790.
    View in: PubMed
  75. Wong ET, Alsop D, Lee D, Tam A, Barron L, Bloom J, Gautam S, Wu JK. Cerebrospinal fluid matrix metalloproteinase-9 increases during treatment of recurrent malignant gliomas. Cerebrospinal Fluid Res. 2008 Jan 11; 5:1. PMID: 18186943; PMCID: PMC2263020.
  76. Drappatz J, Wong ET, Schiff D, Kesari S, Batchelor TT, Ramakrishna N, Weiss S, Doherty L, LaFrankie D, Ciampa A, Smith ST, Zimmerman J, Ostrowsky L, David K, Norden A, Black P, Wen PY. A pilot study of lenalidomide and radiation therapy for patients with newly diagnosed glioblastoma multiforme. International Journal of Radiation Oncology Biology Physics. 2008; in press.
  77. Lu XQ, Shanmugham LN, Mahadevan A, Nedea E, Stevenson MA, Kaplan I, Wong ET, LaRosa S, Wang F, and Berman S. Organ deformation and dose coverage in robotic respiratory tracking treatment. International Journal of Radiation Oncology Biology Physics. 2008; 71(1):281-289.
  78. Wong ET, Huberman M, Lu XQ, Mahadevan A. Bevacizumab reverses cerebral radiation necrosis. Journal of Clinical Oncology. 2008; 26:5649-5650.
  79. Chowdhary S, Wong ET. Commentary: Bevacizumab plus irinotecan for recurrent glioblastoma multiforme. Nature Clinical Practice Neurology. 2008; 4:242-243.
  80. Yu M, Song S, Nguyen S, Jeyapalan S, Groves M, Swanson K, Gautam S, Wong ET. Vascular endothelial growth factor (VEGF) and matrix metalloprotease (MMP) cerebrospinal fluid (CSF) biomarkers in lymphomatous meningitis. Proceedings of the American Society of Clinical Oncologists. 2008.
  81. Wong ET, Brem S. Taming glioblastoma: targeting angiogenesis. J Clin Oncol. 2007 Oct 20; 25(30):4705-6. PMID: 17947716.
    View in: PubMed
  82. Wong ET, Wu JK, Mahadevan A. Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma. Biologics. 2007 Sep; 1(3):321-4. PMID: 19707341; PMCID: PMC2721320.
  83. Wong ET, Brem S. Editorial: Taming glioblastoma: Targeting angiogenesis. Journal of Clinical Oncology. 2007; 25:4795-4796.
  84. Recht L, Mechtler L, Alksne J, Arenson E, Paleologos N, Avgeropoulos N, Hormigo A, Perry J, Raizer J, Robins I, Wong E, Shulman M, Carr L. Long-term safety and steroid-sparing potential of corticorelin acetate injection for treatment of peritumoral brain edema: Third interim report of an open-label study as part of a phase III program. Neuro-Oncology. 2007; 9:570.
  85. Yu M, Song S, Nguyen S, Gu H, Wong ET. Cerebrospinal fluid (CSF) O6-methylguanine-methyltransferase (MGMT) from patients with glioblastoma multiforme. Neuro-Oncology. 2007; 9:549.
  86. Wong ET, Lee D, Tam A, Gautam S, Wu JK. Matrix metalloprotease-9 in cerebrospinal fluid correlates with disease activity in lymphomatous meningitis. Clin Lymphoma Myeloma. 2007 Jan; 7(4):305-8. PMID: 17324339.
    View in: PubMed
  87. Wong ET, Linendoll N. Treatment advances for glioblastomas: tumor markers and targeted treatments. Applied Neurology. 2007; 3:18-22.
  88. Drappatz J, Wong ET, Kesari S, Batchelor T, Schiff D, Doherty L, Gigas D, Weiss S, Ramakrishna N, Black P, Ciampa A, Smith ST, Zimmerman J, Ostrowsky L, David K, Wen P. Pilot safety study of lenalidomide and radiation therapy in patients with newly diagnosed glioblastoma. Neurology. 2007; 68:A289.
  89. Yu M, Song S, Nguyen S, Jeyapalan S, Groves M, Swanson K, Gautam S, Wong ET. Vascular endothelial growth factor (VEGF) and matrix metalloprotease (MMP) cerebrospinal fluid (CSF) biomarkers in lymphomatous meningitis. Neuro-Oncology. 2007; 9:548.
  90. Recht L, Mechtler L, Alksne J, Arenson E, Paleologos N, Avgeropoulos N, Hormigo A, Perry J, Raizer J, Robins I, Wong E, Shulman M, Carr L. Long-term safety and steroid-sparing potential of corticorelin acetate injection for treatment of peritumoral brain edema: Third interim report of an open-label study as part of a phase III program. Neuro-Oncology. 2007; 9:570.
  91. Wong ET, Wu JK, Mahadevan A. Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung cancer. Biologics: Targets and Therapy. 2007; 1:321-324.
  92. Wong ET, Liu XQ, Devulapalli J, Mahadevan A. Cyberknife radiosurgery for basal skull plasmacytoma. Journal of Neuroimaging. 2006; 16(4):1-4.
  93. Wong ET, Lu XQ, Devulapalli J, Mahadevan A. Cyberknife radiosurgery for basal skull plasmacytoma. J Neuroimaging. 2006 Oct; 16(4):361-3. PMID: 17032388.
    View in: PubMed
  94. Wong ET. Is protracted low-dose temozolomide feasible in glioma patients? Neurology. 2006 Aug 08; 67(3):543-4; author reply 543-4. PMID: 16894133.
    View in: PubMed
  95. Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Cancer Res. 2006 Jan 15; 66(2):867-74. PMID: 16424019.
    View in: PubMed
  96. Mechtler L, Alksne J, Wong E, Arenson E, Recht L, Avgeropolous N, Eisenstat D, Hormigo A, Perry J, Raizer J, Shapiro W, Taylor L, Shulman M, Carr L. Interim report of the phase III open-label study of Xerecept (corticorelin acetate injection) for treatment of peritumoral brain edema in patients with primary or secondary brain tumors. Neuro-Oncology. 2006; 8:446-447.
  97. Glantz MJ, Chamberlain MC, Batchelor T, Wong E, Cavalli F, Shapiro WR. Interaction between route of intra-CSF chemotherapy administration and efficacy of therapy in patients with neoplastic meningitis. Proceedings of the American Society of Clinical Oncologists. 2006; 24:65s.
  98. Wong ET. Tumor growth, angiogenesis, and invasion. Journal of Neuro-Oncology. 2006; 77:295-296.
  99. Wong ET, Appignani B, Alsop D, Hackney D, Joseph J, Kasper E, Papavassiliou E. Perfusion-guided brain biopsy for gliomatosis cerebri. Eighth International Symposium on Anti-Angiogenic Agents. La Jolla, CA. 2006.
  100. Wong ET. Tumor growth, invasion, and angiogenesis in malignant gliomas. J Neurooncol. 2006 May; 77(3):295-6. PMID: 16314946.
    View in: PubMed
  101. Wong ET. Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7151s-7157s. PMID: 16203815.
    View in: PubMed
  102. Wong ET. Monoclonal antibody therapy for central nervous system lymphomas: an emerging treatment paradigm. Expert Opin Pharmacother. 2005 Jun; 6(7):1107-14. PMID: 15957965.
    View in: PubMed
  103. Wong ET. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology. 2005 Mar 08; 64(5):934; author reply 934. PMID: 15753455.
    View in: PubMed
  104. Wong ET, Alsop D, Appignani B, Mahadevan A, Lee D, Tam A, Barron L, Bloom J, Hackney D, Wu JK. Phase I study of irinotecan, thalidomide, and doxycycline combination for recurrent malignant gliomas, with correlative 3.0-Tesla arterial spin labeling perfusion imaging and cerebrospinal fluid zymography. Seventh International Symposium on Anit-Angiogenic Agents, La Jolla, CA. 2005.
  105. Appignani B, Alsop D, Hackney D, Wong E, Wu J. Arterial spin labeling perfusion imaging of brain tumors. Radiological Society of North America. 2005.
  106. Wong ET, Barron L, Wu JK. Peripartum pituitary hypertrophy. Neurology Reviews. 2005; 13:9-10.
  107. Wong ET, Appignani B, Wu JK, Mahadevan A, Joseph JJ, Lee D, Tam A, Bloom J, Barron L, Hackney D, Alsop D. Arterial spin labeling MRI detects early recurrence and anti-angiogenic drug effect in recurrent malignant gliomas. Proceedings of the American Society of Clinical Oncologists. 2005; 23:132s.
  108. Wong ET, Tishler R, Barron L, Wu JK. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas. Cancer. 2004 Jul 01; 101(1):139-45. PMID: 15221999.
    View in: PubMed
  109. Wong ET, Berkenblit A. The role of topotecan in the treatment of brain metastases. Oncologist. 2004; 9(1):68-79. PMID: 14755016.
    View in: PubMed
  110. Wong ET. Neoplastic Meningitis. Cancer of the Nervous System, PM Black, JS Loeffler (Eds.). 2004; 683-689.
  111. Wong ET. Cranial Neuropathy. Clinical Practice of Hematology and Oncology:Presentation, Diagnosis, and Treatment. B Furie, RJ Mayer, Pa Cassileth, MG Atkins (Eds.). 2003; 27-31.
  112. Wong ET. The treatment of brain metastasis in the SCLC patient. In Current Perspective on the Treatment of Small Cell Lung Cancer. Oncology Journal Forum. 2003; 9:1-7.
  113. Wong ET. Headache. Clinical Practice of Hematology and Oncology:Presentation, Diagnosis, and Treatment. B Furie, RJ Mayer, Pa Cassileth, MG Atkins (Eds.). 2003; 19-22.
  114. Wong ET. Back Pain. Clinical Practice of Hematology and Oncology:Presentation, Diagnosis, and Treatment. B Furie, RJ Mayer, Pa Cassileth, MG Atkins (Eds.). 2003; 156-164.
  115. Jaeckle KA, Batchelor T, O'Day SJ, Phuphanich S, New P, Lesser G, Cohn A, Gilbert M, Aiken R, Heros D, Rogers L, Wong E, Fulton D, Gutheil JC, Baidas S, Kennedy JM, Mason W, Moots P, Russell C, Swinnen LJ, Howell SB. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol. 2002 May; 57(3):231-9. PMID: 12125986.
    View in: PubMed
  116. Friedberg MH, Wong ET, Wu JK. . Management of brain metastases in melanoma. UpToDate, Rose BD (Ed.). 2002.
  117. Wong ET, Joseph JJ, Tishler RK, Wu JK. Hemangioblastoma. UpToDate, Rose BD (Ed.). 2002.
  118. Chamberlain MC, Gilbert MR, Wong ET. Evaluation and treatment of neoplastic meningitis. 2001.
  119. Wong ET, Louis DT. Case Record of the Massachusetts General Hospital: A 61-year-old man with transient quadriplegia and apnea. New England Journal of Medicine. 2001; 344:832-839.
  120. Freedman SJ, Pantanowitz L, Joseph JJ, Wu J, Wong ET, Dezube BJ. Unusual locations for lymphomas. Case 2. Pineal lymphoma. Journal of Clinical Oncology. 2001; 19(11):2960-2963.
  121. Jaeckle KA, Phuphanich S, Bent MJ, Aiken R, Batchelor T, Campbell T, Fulton D, Gilbert M, Heros D, Rogers L, O'Day SJ, Akerley W, Allen J, Baidas S, Gertler SZ, Greenberg HS, LaFollette S, Lesser G, Mason W, Recht L, Wong E, Chamberlain MC, Cohn A, Glantz MJ, Gutheil JC, Maria B, Moots P, New P, Russell C, Shapiro W, Swinnen L, Howell SB. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br J Cancer. 2001 Jan; 84(2):157-63. PMID: 11161370; PMCID: PMC2363714.
  122. Wong ET, Wu JK, Hariharan S. Clinical presentation and diagnosis of brain tumors. UpToDate, Rose BD (Ed.). 2000.
  123. Wong ET, Joseph JJ. Meningeal carcinomatosis in lung cancer. Case 1. Carcinomatous leptomeningeal metastases. Journal of Clinical Oncology. 2000; 18(15):2926-2927.
  124. Hess KR, Wong ET, Jaeckle KA, Kyritsis AP, Levin VA, Prados MD, Yung WK. Response and progression in recurrent malignant glioma. Neuro Oncol. 1999 10; 1(4):282-8. PMID: 11550320; PMCID: PMC1920759.
  125. Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol. 1999 Aug; 17(8):2572-8. PMID: 10561324.
    View in: PubMed
  126. Wong ET. Recurrent cystic radiation necrosis of the brain. Oncol Rep. 1998 May-Jun; 5(3):685-7. PMID: 9538176.
    View in: PubMed
  127. Wong ET, O'Brien S. Leptomeningeal disease in pre-leukemic syndrome: cytogenetic abnormality versus cellular morphology. Oncol Rep. 1998 Mar-Apr; 5(2):493-5. PMID: 9468587.
    View in: PubMed
  128. Wong ET, Jackson EF, Hess KR, Schomer DF, Hazle JD, Kyritsis AP, Jaeckle KA, Yung WK, Levin VA, Leeds NE. Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology. 1998 Mar; 50(3):777-81. PMID: 9521274.
    View in: PubMed
  129. Hess KR, Wong ET, Yung WKA. Chemotherapy response criteria in malignant gliomas. Neurology. 1998; 50:1196-1998.
  130. Wong ET, Gunes S, Gaughan E, Patt RB, Ginsberg LE, Hassenbusch SJ, Payne R. Palliation of intractible cancer pain by MRI-guided cingulotomy. Clinical Journal of Pain. 1997; 13(3):260-263.
  131. Wong ET, Portlock CS, O'Brien JP, DeAngelis LM. Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. Neurology. 1996 Jun; 46(6):1543-7. PMID: 8649545.
    View in: PubMed
  132. Wong ET, Ginsberg LE, Patt RB, Payne R. Radiation insufficiency fracture of the sacrum may simulate metastatic prostate cancer. Primary Care & Cancer. 1996; 16:12-17.
  133. Wong ET, Malkin MG, Patt RB. Pain from a shunt-induced abdominal phlegmon in a cancer patient. Primary Care & Cancer. 1996; 17:22-27.
  134. Wong ET, Holstad SG, Mennerick SJ, Hong SE, Zorumski CF, Isenberg KE. Analysis of recombinant neuronal nicotinic acetylcholine receptors by transient expression in eucaryotic cells in vitro. Neuroscience Protocols. 1996; 20:1-11.
  135. Wong ET, Holstad SG, Mennerick SJ, Hong SE, Zorumski CF, Isenberg KE. Pharmacological and physiological properties of a putative ganglionic nicotinic receptor, alpha 3 beta 4, expressed in transfected eucaryotic cells. Brain Res Mol Brain Res. 1995 Jan; 28(1):101-9. PMID: 7707862.
    View in: PubMed
  136. Vahdat L, Wong ET, Wile MJ, Rosenblum M, Foley KM, Warrell RP. Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia. Blood. 1994 Nov 15; 84(10):3429-34. PMID: 7949097.
    View in: PubMed
  137. Wasserman AJ, Doillon CJ, Glasgold AI, Kato YP, Christiansen D, Rizvi A, Wong E, Goldstein J, Silver FH. Clinical application of scanning electron microscopy in analysis of collagenous biomaterials. Scanning Microscopy. 1988; 2:1635-1646.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Wong's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (324)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.